English

Choose language

Back

  • Deutsch

  • ελληνική

  • English

  • Español

  • Français

  • Polski

  • Português

  • Русский

  • Українська


English

How do you prefer to top up your account?

* We don't charge any commission for making deposits into your account

Shares Biogen

16.27%
Growth potential
244 USD
Price per share
USD
-
Dividend income
Biogen sold by lots comprising 1 pc.
Enter the number of securities
Order price:
Brokerage commission:
Transfer commission:
Science that truly matters
Why invest in Biogen?
  • Number 245 in Forbes Global 500 by revenue in 2018
  • Net profit increased by 20% to $1.40B in Q1 2019
  • One of the world's largest biotech companies
  • The largest multinational bio pharma corporation


1d
1w
1mo
6mths
All the time
Recommendations of the largest investment banks
DZ Bank
Buy
265 USD
10.11.2020
H.C. Wainwright
Buy
289 USD
09.11.2020
Cowen
Hold
215 USD
09.11.2020
BofA Securities
Sell
240 USD
09.11.2020
Financial indicators
Capitalization
67.24B USD
P / E
21.82
Profit
13.23B USD
Net profit
10.64B USD
The general recommendation of investment banks

Hold

Based on the analytics from 35 of the world's largest investment banks over the past 3 months

Forecasted prices

Target price

291.4 USD

(19.43% Growth potential)

Based on the data from 35 of the leading investment banks

American Biogen Inc. is a global leader in biotechnology, engaged in scientific research and development of a wide range of medications for treatment of people with hematological, neuralgic and autoimmune diseases. As of today, Biogen is the third largest biotech company in the world. Company's financial gain as of 2015 equaled almost $ 3 billion. Scientific centers and hubs of Biogen Inc. are allocated in over 30 countries, where about 8,000 employees are engaged in various activities. One of the latest projects is Alprolix. It gained a worldwide recognition no more than a year after its first release in 2014 and was highly appraised by Medical Reviewers. Alprolix prevents most fatal bleedings and acts as a prophylactic agent for people with hemophilia.

Receive ideas for profitable investments - faster than the market

We will be sending you a letter once a week with the most relevant information

Congratulations!

Now you will always be aware of which stocks are more profitable to invest in